Acute Treatment Response in Outpatients with Panic Disorder: High Versus Low Depressive Symptoms

REFERENCES

• Alessi NE, Robbins DR, Dilsaver SC: Panic and depressive disorders among psychiatrically hospitalized adolescents. Psy-chiatry Res 1987; 20:275–288
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association Committee on Nomencla-ture and Statistics: Diagnostic and Statistical Manual of Mental Disorders, Rev 3rd ed. Washington, DC: American Psychiatric Press; 1987
   Google Scholar
• Barlow DH, DiNardo PA, Vermilyea BB, Vermilyea J, Blanchard EB: Comorbidity and depression among the anxi-ety disorders. J Nero Ment Dis 1986; 174:63–72
   PubMed Web of Science ®Google Scholar
• Benfield P, Ward A: Fluvoxamine: A review of its pharma-codynamics and pharmacokinetic properties and therapeutic efficacy in depressive illness. Drugs 1986; 32:313–334
   PubMed Web of Science ®Google Scholar
• Black DW, Wesner R, Bowers W, Gabel J: A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993; 50:44–50
   PubMed Web of Science ®Google Scholar
• Black DW, Wesner R, Gabel J, Bowers W: Predictors of treat-ment response in 66 patients with panic disorder. J Affect Dis 1994; 30:233–241
   Web of Science ®Google Scholar
• Breier A, Charney DS, Heninger OR: Major depression in patients with agoraphobia and panic disorder. Arch Gen Psy-chiatry 1984; 41:1129–1135
   PubMed Web of Science ®Google Scholar
• Breier A, Charney DS, Heninger GR: The diagnostic validity of anxiety disorders and their relationship to depressive ill-ness. Am J Psychiatry 1985; 142:787–797
   PubMed Web of Science ®Google Scholar
• Clancy J, Noyes R, Hoenk PR, Slymen DJ: Secondary de-pression and anxiety neurosis. J Nerv Merit Dis 1978; 166:846–850
   PubMed Web of Science ®Google Scholar
• Clum GA, Pendrey D: Depression symptomatology as a non-requisite for successful treatment of panic with antidepressant medication. J Arvciety Dis 1987; 1:337–344
   Google Scholar
• Coryell W, Endicott J, Andreasen NC, Keller MB, Clayton PJ, Hirschfeld RMA, Scheftner WA, Winokur G: Depression and panic attacks: The significance of overlap as reflected in follow-up in panic study data. Am J Psychiatry 1988; 145:293–300
   PubMed Web of Science ®Google Scholar
• Garvey MJ, Tollefson GD, Tuason VB: Comparison of major depression with and without panic attacks. Compr Psychiatry 1987; 28:65–67
   Google Scholar
• Grunhaus L: Clinical and psychobiological characteristics of simultaneous panic disorder and major depression. Am J Psy-chiatry 1988; 145:1214–1221
   PubMed Web of Science ®Google Scholar
• Grunhaus L, Pande AC, Brown MB, Greden JF: Clinical characteristics of patients with concurrent major depressive disorder and panic disorder. Am .1- Psychiatry 1994; 151:541–546
   PubMedGoogle Scholar
• Guy W: ECDEU Assessment Manual for Psychopharmacol-ogy. U.S. Department of Health Education and Welfare, Pub-lication ADM 76–338. Washington, DC: U.S. Government Printing Office; 1976
   Google Scholar
• Hodgson RJ, Rachman S: Obsessive-compulsive complaints. Behav Res Ther 1977; 15:389–395
   PubMed Web of Science ®Google Scholar
• Hyler SE, Reider RO, Spitzer RL: Personality Diagnostic Questionnaire, revised. New York: New York State Psychiatric Institute; 1987
   Google Scholar
• Keller MD, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K, Klerman GL: Influence of depression on the treatment of panic disorder with imipramine, alprazolam, or placebo. J Af-fect Dis 1993; 28:27–38
   PubMed Web of Science ®Google Scholar
• Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burroughs GD, Noyes R, Dupont RL: Secondary depression in panic disorder and agoraphobia. 1. Frequency, severity, and response to treatment. Arch Gen Psychiatry 1988; 45:437–443
   PubMedGoogle Scholar
• Marks I: Are there anticompulsive or antipanic drugs? Review of the evidence. Br J Psychiatry 1983; 143:338–347
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:383–389
   Web of Science ®Google Scholar
• Noyes R, Reich J, Clancy J, O'Gorman TW: Reduction in hypochondriasis with treatment of panic disorder. Br J Psy-chiatry 1986; 149:631–635
   PubMed Web of Science ®Google Scholar
• Pfohl B, Zimmerman M, Blum NL: Structured Interview for DSM-III-R Personality Disorders. Ames: University of Iowa Department of Psychiatry; 1989
   Google Scholar
• Pilowsky I, Spence ND: Manual for the Illness Behavior Questionnaire, 2nd ed. Adelaide, Australia: Department of Psychiatry, University of Adelaide; 1983
   Google Scholar
• Rosenberg R, Bech P, Mellergard M, Ottosson JO: Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome on alprazolam and imipramine treat-ment. Acta Psychiat Scand (Suppl) 1991; 365:39–45
   Google Scholar
• SAS Institute Inc: SAS/STAT User's Guide, Version 6, 4th ed. Cary, NC: SAS Institute; 1989
   Google Scholar
• Sheehan DV: The Anxiety Disease. New York: Bantam Books; 1986
   Google Scholar
• Sheehan DV, Ballenger JC, Jacobson G: Treatment of endo-genous anxiety with phobic, hysterical, or hypochondriacal symptoms. Arch Gen Psychiatry 1980; 37:51–59
   PubMed Web of Science ®Google Scholar
• Snaith RP, Baugh SJ, Clayden AD, Husain A, Supple MA: The Clinical Anxiety Scale: An instrument derived from the Hamilton Anxiety Scale. Br J Psychiatry 1982; 141:518–523
   PubMed Web of Science ®Google Scholar
• Tyrer P, Candy J, Kelly D: A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety. Psychopharmacology 1973; 132:237–254
   Google Scholar
• Van Valkenburg CH, Akiskal HS, Puzantian V, Rosenthal T: Anxious depressions. .1 Affect Dis 1984; 6:67–82
   PubMed Web of Science ®Google Scholar
• Weissman MM, Merikangas KR, Wickramaratne P, et al.: Un-derstanding the clinical heterogeneity of major depression us-ing family data. Arch Gen Psychiatry 1986; 43:430–434
   PubMedGoogle Scholar
• Zitrin CM, Klein M, Woerner MV: Treatment of agoraphobia with group exposure in vivo and imipramine. Arch Gen Psy-thiatty 1980; 37:63–72
   PubMed Web of Science ®Google Scholar